INCREASED RISK FOR TRANSVERSE DIGITAL DEFICIENCY AFTER CHORIONIC VILLUS SAMPLING - RESULTS OF THE UNITED-STATES MULTISTATE CASE-CONTROL STUDY, 1988-1992
Rs. Olney et al., INCREASED RISK FOR TRANSVERSE DIGITAL DEFICIENCY AFTER CHORIONIC VILLUS SAMPLING - RESULTS OF THE UNITED-STATES MULTISTATE CASE-CONTROL STUDY, 1988-1992, Teratology, 51(1), 1995, pp. 20-29
Although numerous infants have been reported with transverse limb defi
ciencies after their mothers had undergone chorionic villus sampling (
CVS), it has been unclear whether the procedure caused these defects.
We report the results of the first multistate case-control study to as
sess and quantify the risk for specific limb deficiencies associated w
ith CVS. Case subjects were 131 infants with nonsyndromic limb deficie
ncy ascertained from 7 population-based birth defect surveillance prog
rams, and born from 1988-1992 to mothers 34 years of age or older. Con
trol subjects were 131 infants with other birth defects. We ascertaine
d exposure to CVS from medical records and maternal and physician ques
tionnaires. We assessed rates and timing of exposure to CVS, and estim
ated relative and absolute risks for anatomic subtypes of limb deficie
ncy. The odds ratio for all types of limb deficiency after CVS from 8-
12 weeks' gestation was 1.7 (95% confidence interval, 0.4-6.3). For sp
ecific anatomic subtypes, the strongest association was for transverse
digital deficiency (odds ratio = 6.4; 95% confidence interval, 1.1-38
.6). The risk for transverse digital deficiency increased with earlier
gestational exposure (P < 0.01 for trend). We estimated that the abso
lute risk for transverse digital deficiency in infants after CVS was 1
per 2,900 births (0.03%). Exposure to CVS was associated with a sixfo
ld increase in risk for transverse digital deficiency. The causality o
f this association is supported by its strength, specificity, biologic
plausibility, and consistency with the results of previous studies. A
lthough some centers already inform patients about risk for limb defic
iency, this study quantifies the magnitude of risk associated with CVS
from 8-12 weeks' gestation. (C) 1995 Wiley-Liss, Inc.